Thomas Gross, MD, PhD (IMAGE)

University of Colorado Anschutz Medical Campus

Thomas Gross, MD, PhD

Caption

Thomas Gross, MD, PhD, leads phase III clinical trial showing benefit of rituximab in Burkitt lymphoma

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.